Image

Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors

Investigational Treatment for Advanced Solid Tumors Using Investigational Medication

Recruiting
18-75 years
All
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates advanced solid tumors. The purpose of this study is to learn if the investigational medication VB15010 is safe and can be tolerated by patients.

The study evaluates the safety and anti-cancer activity of VB15010. Researchers want to find out how this investigational treatment works in patients.

  • Who can participate: Adults aged 18 and older with confirmed advanced malignancy and progressive cancer can participate. Participants must have adequate organ and marrow function and a specific gene mutation.
  • Study details: Participants will take investigational medication tablets to evaluate their effects. Some may receive an inactive substance that looks like the investigational medication but does not contain any medicine.
Print
Study details
    Cancer
    Neoplasms
    Neoplasms
    Breast
    Tumor
    PARP
    Ovarian Neoplasms
    Prostatic Cancer
    Pancreatic Cancer
    Breast Cancer
    Biliary Cancer
    Colorectal Cancer

NCT06819215

Zhejiang Yangli Pharmaceutical Technology Co., Ltd.

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.